Verastem Oncology (VSTM) Announces Proposed Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Verastem (VSTM) PT Lowered to $7 at B.Riley
July 24, 2024 7:02 AM EDTB.Riley analyst Kalpit Patel lowered the price target on Verastem (NASDAQ: VSTM) to $7.00 (from $21.00) while maintaining a Buy rating.
The analyst comments "Verastem (VSTMBuy, $7 PT) announced a proposed public offering after market close on 7/23/24. Our enthusiasm for the drugs potential... More
